1,686.26 1,476.04 210.22 14.2 Finance costs 1,502.50 1,402.44 100.06 7.1 Income tax expense 870.89 863.24 7.65 0.9 Total expenses 9,562.76 8,565.17 997.59 11.6 5,531.31 5,914.89 (383.58) (6.5) Non

% O&M 1,145 1,247 9.0% Others 445 911 104.9% Cost of sales and services 14,706 16,674 13.4% SG&A 587 709 20.8% Depreciation 1,827 2,100 15.0% Total expenses 17,119 19,483 13.8% Natural Gas  Natural gas

increased . 1.2 Cost of hospital operations increased by Baht 33.70 million or 7.89% mainly due to the Medical personal expenses also increased because of the expanding capacity of subsidiaries. 1.3 Selling

% EBIT 16.10 4.14 11.95 288% EBITDA 36.93 29.54 7.38 25% EBITDA margin 17% 16% Finance cost -1.22 -0.68 -0.55 80% Income tax expenses -2.74 0.33 -3.07 934% Net income for period 12.13 3.79 8.33 220

, we also faced the need to do earlier than expected preventive maintenance, which reduced our utilization rate and added to the fix costs. SG&A was slightly higher as there were some one shot impacts

maintenance schedule in this quarter as there was in Q4/2019, as well as the reduced financial costs after the financial restructuring of the short-term loans repayment plan during Q4/2019 and Q1/2020. When

revenues 7,542 4,162 3,380 81.2 Cost of service 2,480 2,320 160 6.9 Selling and administrative expenses 330 313 17 5.4 Finance cost 324 320 4 1.3 Interest expense from the MRT Purple Line Project 97 110 (13

765 1,852 2,409 81 883 (3%) (4%) 33% 15% Total Revenues 5,459 5,507 1% 5,248 5,226 (0.4%) Operating and administrative expenses Expected credit loss Finance costs Other expenses 2,029 2,094 527 5 2,187

mainly to controlled network OPEX and marketing expenses. As a result, AIS reported EBITDA and net profit of Bt18,998mn and Bt8,005mn, respectively, both growing +11% YoY and flat QoQ. Revised revenue and

) that grew by 18% Q-o-Q and 81% Y-o-Y (Table 5), which on the other hand caused a reduction in production efficiency. Furthermore, as total production volume decreased, product costs rose, all of which